| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
| | FI | PI | | Elyfem 20 | 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Berlis AG | B / LPPV | FB | | G |  |
| | FI | PI | | Elyfem 20 | 3 x 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Berlis AG | B / LPPV | FB | | G |  |
| | FI | PI | | Elyfem 20 | 6 x 21 | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Berlis AG | B / LPPV | FB | | G |  |
| | FI | PI | | Elyfem 30 | 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Berlis AG | B / LPPV | FB | | G |  |
| | FI | PI | | Elyfem 30 | 3 x 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Berlis AG | B / LPPV | FB | | G |  |
| | FI | PI | | Elyfem 30 | 6 x 21 | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Berlis AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levonorgestrel Ethinylestradiol Stada | 21 | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Levonorgestrel Ethinylestradiol Stada | 3 x 21 | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Levonorgestrel Ethinylestradiol Stada | 6 x 21 | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Microgynon 50 | 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Bayer (Schweiz) AG | B / LPPV | FB | | G |  |
| | FI | PI | | Microgynon 50 | 3 x 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Bayer (Schweiz) AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Microgynon 30 | 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Bayer (Schweiz) AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Microgynon 30 | 3 x 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Bayer (Schweiz) AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Microgynon 30 | 6 x 21 | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Bayer (Schweiz) AG | B | FB | | G |  |
| | FI | PI | | Effilevo 0.10 mg / 0.02 mg | 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Effik SA | B / LPPV | FB | | G |  |
| | FI | PI | | Effilevo 0.10 mg / 0.02 mg | 3 x 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Effik SA | B / LPPV | FB | | G |  |
| | FI | PI | | Effilevo 0.10 mg / 0.02 mg | 6 x 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Effik SA | B / LPPV | FB | | G |  |
| | FI | PI | | Effilevo Conti | 28 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Effik SA | B / LPPV | FB | | G |  |
| | FI | PI | | Effilevo Conti | 3 x 28 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Effik SA | B / LPPV | FB | | G |  |
| | FI | PI | | Effilevo Conti | 6 x 28 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Effik SA | B / LPPV | FB | | G |  |
| | FI | PI | | Levina 20 | 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levina 20 | 3 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levina 20 | 6 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levina 30 | 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Levina 30 | 3 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Levina 30 | 6 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Spirig HealthCare AG | B | FB | | G |  |
| | FI | PI | | Levomin 20 | 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levomin 20 | 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B | FB | | G |  |
| | FI | PI | | Levomin 20 | 3 x 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levomin 20 | 3 x 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B | FB | | G |  |
| | FI | PI | | Levomin 20 | 6 x 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levomin 20 | 6 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B | FB | | G |  |
| | FI | PI | | Levomin 30 | 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levomin 30 | 3 x 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B / LPPV | FB | | G |  |
| | FI | PI | | Levomin 30 | 6 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Dermapharm AG | B | FB | | G |  |
| | FI | PI | | Lisenia 30 | 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / LPPV | FB | | G |  |
| | FI | PI | | Lisenia 30 | 3 x 21 Tablette(n) | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / LPPV | FB | | G |  |
| | FI | PI | | Lisenia 30 | 6 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Mizzi Gynial | 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Gynial AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Mizzi Gynial | 3 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Gynial AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Mizzi Gynial | 6 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Gynial AG | B | FB | | G |  |
| | FI | PI | | Ologynelle | 28 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Labatec Pharma SA | B | FB | | G |  |
| | FI | PI | | Ologynelle | 3 x 28 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Labatec Pharma SA | B | FB | | G |  |
| | FI | PI | | Seasonique 150mcg/30mcg und 10mcg | 91 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe Filmtabletten: Ethinyl Estradiolum | Labatec Pharma SA | B / LPPV | FB | | G |  |
| | FI | PI | CM | Soffi Gynial 0.02 mg/0.10 mg | 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Gynial AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Soffi Gynial 0.02 mg/0.10 mg | 3 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Gynial AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Soffi Gynial 0.02 mg/0.10 mg | 6 x 21 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | Gynial AG | B / LPPV | FB | | G |  |
| | FI | PI | | Ologyn | 21 Tablette(n) | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Labatec Pharma SA | B / LPPV | FB | | G |  |
| | FI | PI | | Ologyn | 3 x 21 Tablette(n) | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Labatec Pharma SA | B / LPPV | FB | | G |  |
| | FI | PI | | Ologyn | 6 x 21 Tablette(n) | PA | PA | k.A. | | Tabletten: 2 Wirkstoffe | Labatec Pharma SA | B / LPPV | FB | | G |  |
| | FI | PI | CM | Miranova | 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Bayer (Schweiz) AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Miranova | 3 x 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Bayer (Schweiz) AG | B / LPPV | FB | | G |  |
| | FI | PI | CM | Miranova | 6 x 21 | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Bayer (Schweiz) AG | B | FB | | G |  |
| | FI | PI | | Neogynon 21 | 3 x 21 Dragée(s) | PA | PA | k.A. | | Dragées: 2 Wirkstoffe | Schering (Schweiz) AG | B | FB | | G |  |